forecast

CGM Competition Is Not the Key Risk

Competition is not the main threat to Dexcom because manufacturing difficulty has created a graveyard of failed CGM attempts, so the market should remain a stable duopoly for the foreseeable future.

forecastpending

Speaker

Aneal

Evidence Quote

“competition is not one of them. This is a focus from Wall Street, but from studying the history of CGMs, there has been a graveyard of CGMs in development”

Source

Dexcom: Digitizing Diabetes Management— Business Breakdowns
Created: 11/20/2026, 5:18:27 AM

Your notes

Loading notes...